Involvement of MAPKs, NF-κB and p300 co-activator in IL-1β-induced cytosolic phospholipase A2 expression in canine tracheal smooth muscle cells

Toxicology and Applied Pharmacology

Volumn 232, Issue 3, 2008, Pages 396-407

  Luo, Shue Fen ^a   Lin, Chih Chung ^a   Chen, Hsin Chieh ^a   Lin, Wei Ning ^a   Lee, I Ta ^a   Lee, Chiang Wen ^a   Hsiao, Li Der ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

cPLA2; IL 1 ; MAPKs; NF B; PGE2

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROTEIN P300;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRACHEA MUSCLE; WESTERN BLOTTING;

ANIMALS; CYTOSOL; DINOPROSTONE; DOGS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; P300-CBP TRANSCRIPTION FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRACHEA;

EID: 53449086884     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.07.019     Document Type: Article

References (65)

1. Andersen S., Sjursen W., Laegreid A., Volden G., and Johansen B. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue. Inflammation 18 (1994) 1-12
2. Arai K., Lee S.R., and Lo E.H. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 43 (2003) 254-264
3. Balsinde J., Balboa M.A., Insel P.A., and Dennis E.A. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 175-189
4. Barnes P.J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J. Allergy Clin. Immunol. 83 (1989) 1013-1026
5. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13681-13686
6. Berenbaum F., Humbert L., Bereziat G., and Thirion S. Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J. Biol. Chem. 278 (2003) 13680-13687
7. Bian Z.M., Elner S.G., Yoshida A., Kunkel S.L., Su J., and Elner V.M. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. Exp. Eye Res. 73 (2001) 111-121
8. Bonventre J.V., and Sapirstein A. Group IV cytosolic phospholipase A2 (PLA2) function: insights from the knockout mouse. Adv. Exp. Med. Biol. 507 (2002) 25-31
9. Borsch-Haubold A.G., Bartoli F., Asselin J., Dudler T., Kramer R.M., pitz-Castro R., Watson S.P., and Gelb M.H. Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J. Biol. Chem. 273 (1998) 4449-4458
10. Boulton T.G., Yancopoulos G.D., Gregory J.S., Slaughter C., Moomaw C., Hsu J., and Cobb M.H. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Scifsence 249 (1990) 64-67
11. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., and Wasserman S.I. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89 (1992) 958-967
12. Cao D., Bromberg P.A., and Samet J.M. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. Am. J. Respir. Cell Mol. Biol. 37 (2007) 232-239
13. Chan H.M., and La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114 (2001) 2363-2373
14. Clark J.D., Schievella A.R., Nalefski E.A., and Lin L.L. Cytosolic phospholipase A2. J. Lipid Mediat. Cell Signal. 12 (1995) 83-117
15. Cui X., Zhang L., Luo J., Rajasekaran A., Hazra S., Cacalano N., and Dubinett S.M. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer. Oncogene 26 (2007) 4253-4260
16. Deng W.G., Zhu Y., and Wu K.K. Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 103 (2004) 2135-2142
17. Dennis E.A. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22 (1997) 1-2
18. DeWitt D.L. Cox-2-selective inhibitors: the new super aspirins. Mol. Pharmacol. 55 (1999) 625-631
19. Dieter P., Kolada A., Kamionka S., Schadow A., and Kaszkin M. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2. Cell Signal. 14 (2002) 199-204
20. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
21. Dolan-O'Keefe M., Chow V., Monnier J., Visner G.A., and Nick H.S. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (2000) L649-L657
22. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
23. Ghosh M., Stewart A., Tucker D.E., Bonventre J.V., Murphy R.C., and Leslie C.C. Role of cytosolic phospholipase A(2) in prostaglandin E(2) production by lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 30 (2004) 91-100
24. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
25. Gilroy D.W., Newson J., Sawmynaden P., Willoughby D.A., and Croxtall J.D. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 18 (2004) 489-498
26. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000) 1553-1577
27. Goppelt-Struebe M., and Rehfeldt W. Glucocorticoids inhibit TNF alpha-induced cytosolic phospholipase A2 activity. Biochim. Biophys. Acta 1127 (1992) 163-167
28. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
29. Henderson Jr. W.R., Tang L.O., Chu S.J., Tsao S.M., Chiang G.K., Jones F., Jonas M., Pae C., Wang H., and Chi E.Y. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165 (2002) 108-116
30. Hirabayashi T., and Shimizu T. Localization and regulation of cytosolic phospholipase A(2). Biochim. Biophys. Acta. 1488 (2000) 124-138
31. Hoeck W.G., Ramesha C.S., Chang D.J., Fan N., and Heller R.A. Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4475-4479
32. Hsieh H.L., Wu C.Y., Hwang T.L., Yen M.H., Parker P., and Yang C.M. BK-induced cytosolic phospholipase A2 expression via sequential PKC-delta, p42/p44 MAPK, and NF-kappaB activation in rat brain astrocytes. J. Cell Physiol. 206 (2006) 246-254
33. Hulkower K.I., Wertheimer S.J., Levin W., Coffey J.W., Anderson C.M., Chen T., DeWitt D.L., Crowl R.M., Hope W.C., and Morgan D.W. Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. Arthritis Rheum. 37 (1994) 653-661
34. Jackson B.A., Goldstein R.H., Roy R., Cozzani M., Taylor L., and Polgar P. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun. 197 (1993) 1465-1474
35. Joo M., Wright J.G., Hu N.N., Sadikot R.T., Park G.Y., Blackwell T.S., and Christman J.W. Yin yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L1219-L1226
36. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
37. Lee C.W., Lin C.C., Lin W.N., Liang K.C., Luo S.F., Wu C.B., Wang S.W., and Yang C.M. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L799-L812
38. Leslie C.C. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272 (1997) 16709-16712
39. Lin C.C., Sun C.C., Luo S.F., Tsai A.C., Chien C.S., Hsiao L.D., Lee C.W., Hsieh J.T., and Yang C.M. Induction of cyclooxygenase-2 expression in human tracheal smooth muscle cells by interleukin-1beta: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB. J. Biomed. Sci. 11 (2004) 377-390
40. Lyss G., Knorre A., Schmidt T.J., Pahl H.L., and Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J. Biol. Chem. 273 (1998) 33508-33516
41. Marshall C.J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4 (1994) 82-89
42. Nagase T., Uozumi N., Ishii S., Kita Y., Yamamoto H., Ohga E., Ouchi Y., and Shimizu T. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat. Med. 8 (2002) 480-484
43. Nagase T., Uozumi N., Ishii S., Kume K., Izumi T., Ouchi Y., and Shimizu T. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat. Immunol. 1 (2000) 42-46
44. Newton R., Cambridge L., Hart L.A., Stevens D.A., Lindsay M.A., and Barnes P.J. The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes. Br. J. Pharmacol. 130 (2000) 1353-1361
45. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., and Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem. Biophys. Res. Commun. 237 (1997) 28-32
46. Nie M., Pang L., Inoue H., and Knox A.J. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol. Cell. Biol. 23 (2003) 9233-9244
47. Park G.Y., Joo M., Pedchenko T., Blackwell T.S., and Christman J.W. Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L956-L962
48. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., and Rothe M. Identification and characterization of an IkappaB kinase. Cell 90 (1997) 373-383
49. Roshak A.K., Jackson J.R., McGough K., Chabot-Fletcher M., Mochan E., and Marshall L.A. Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J. Biol. Chem. 271 (1996) 31496-31501
50. Schalkwijk C., Pfeilschifter J., Marki F., and van den B.H. Interleukin-1 beta, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem. Biophys. Res. Commun. 174 (1991) 268-275
51. Singh R.P., Dhawan P., Golden C., Kapoor G.S., and Mehta K.D. One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. J. Biol. Chem. 274 (1999) 19593-19600
52. Six D.A., and Dennis E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19
53. Subbaramaiah K., Hart J.C., Norton L., and Dannenberg A.J. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275 (2000) 14838-14845
54. Uozumi N., Kume K., Nagase T., Nakatani N., Ishii S., Tashiro F., Komagata Y., Maki K., Ikuta K., Ouchi Y., Miyazaki J., and Shimizu T. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390 (1997) 618-622
55. Vadas P., Browning J., Edelson J., and Pruzanski W. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediat. 8 (1993) 1-30
56. Van P.V., Refaat Z., Dessev C., Blaine S., Wick M., Butterfield L., Han S.Y., Heasley L.E., and Nemenoff R.A. Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J. Biol. Chem. 276 (2001) 1226-1232
57. Wang C.C., Lin W.N., Lee C.W., Lin C.C., Luo S.F., Wang J.S., and Yang C.M. Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-kappaB in IL-1beta-induced VCAM-1 expression in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L227-L237
58. Wong D.A., Kita Y., Uozumi N., and Shimizu T. Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). J. Exp. Med. 196 (2002) 349-357
59. Woronicz J.D., Gao X., Cao Z., Rothe M., and Goeddel D.V. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278 (1997) 866-869
60. Wu C.Y., Hsieh H.L., Jou M.J., and Yang C.M. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J. Neurochem. 90 (2004) 1477-1488
61. Wu T., Levine S.J., Lawrence M.G., Logun C., Angus C.W., and Shelhamer J.H. Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2. J. Clin. Invest. 93 (1994) 571-577
62. Xue S., Slater D.M., Bennett P.R., and Myatt L. Induction of both cytosolic phospholipase A2 and prostaglandin H synthase-2 by interleukin-1 beta in WISH cells is inhibited by dexamethasone. Prostaglandins 51 (1996) 107-124
63. Yang C.M., Chien C.S., Hsiao L.D., Luo S.F., and Wang C.C. Interleukin-1beta-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-kappaB pathways in canine tracheal smooth muscle cells. Cell Signal 14 (2002) 899-911
64. Yang C.M., Hsieh H.L., and Lee C.W. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung. Med. J. 28 (2005) 813-823
65. Ziegler-Heitbrock H.W., Sternsdorf T., Liese J., Belohradsky B., Weber C., Wedel A., Schreck R., Bauerle P., and Strobel M. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J. Immunol. 151 (1993) 6986-6993